# Determination of related substances in disulfide-rich peptide ziconotide by establishing tandem mass spectrometry methods.

> PubMed lists PMID 39386004 in Journal of pharmaceutical analysis as Journal Article, with publication-date metadata of 2024-07-02 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-39386004-ziconotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2024-10-11
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-14
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-39386004-ziconotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39386004-ziconotide-v1.json
- Content SHA-256: `d015c34a30bf12825b41feda5355cc2b3c352263f3cbaacec74c04156865ed8f`

## Claims and source pins

### Headline

Determination of related substances in disulfide-rich peptide ziconotide by establishing tandem mass spectrometry methods. ([`pubmed-observation-pmid-39386004-2024-10-11-e3d4f35f6429`](#source-pubmed-observation-pmid-39386004-2024-10-11-e3d4f35f6429))

### Summary

PubMed lists PMID 39386004 in Journal of pharmaceutical analysis as Journal Article, with publication-date metadata of 2024-07-02 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39386004-2024-10-11-e3d4f35f6429`](#source-pubmed-observation-pmid-39386004-2024-10-11-e3d4f35f6429))

### Paragraph 1

PubMed lists PMID 39386004 in Journal of pharmaceutical analysis as Journal Article, with publication-date metadata of 2024-07-02 (day precision). PeptideScanner associated the retained record with the identity slug ziconotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-39386004-2024-10-11-e3d4f35f6429`](#source-pubmed-observation-pmid-39386004-2024-10-11-e3d4f35f6429))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-39386004-2024-10-11-e3d4f35f6429`](#source-pubmed-observation-pmid-39386004-2024-10-11-e3d4f35f6429))

## Sources

<a id="source-pubmed-observation-pmid-39386004-2024-10-11-e3d4f35f6429"></a>
- **Determination of related substances in disulfide-rich peptide ziconotide by establishing tandem mass spectrometry methods. · retained source version 1:2024-10-11:current:e3d4f35f6429ee1827d74e270d82c7539c40fc0b12bcb9c49e51c9105d5deeb2** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/39386004/) (`pubmed-observation-pmid-39386004-2024-10-11-e3d4f35f6429`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Determination of related substances in disulfide-rich peptide ziconotide by establishing tandem mass spectrometry methods." Version 1, published 2026-08-14. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-39386004-ziconotide-v1.json SHA-256: d015c34a30bf12825b41feda5355cc2b3c352263f3cbaacec74c04156865ed8f.

